Silent cortical neuronal damage in atherosclerotic disease of the major cerebral arteries.
書誌事項
- 公開日
- 2011-03
- 資源種別
- journal article
- 権利情報
-
- c 2011 ISCBFM
- This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
- DOI
-
- 10.1038/jcbfm.2010.176
- 公開者
- Nature Publishing Group
この論文をさがす
説明
In atherosclerotic internal carotid artery (ICA) or middle cerebral artery (MCA) disease, hemodynamic compromise may cause selective neuronal damage manifested as loss of central benzodiazepine receptors (BZRs) in the normal-appearing cerebral cortex, without overt episode of stroke. To investigate the association of decreases in cortical BZRs with hemodynamic compromise and the effect of angiotensin receptor blockers (ARBs) on these receptors in patients whose atherosclerotic ICA or MCA disease is asymptomatic, we measured BZRs using positron emission tomography and (11)C-flumazenil in 79 patients with asymptomatic atherosclerotic ICA or MCA disease and no cortical infarction. Three-dimensional stereotactic surface projections were used to calculate the BZR index, a measure of abnormally decreased BZRs in the cerebral cortex within the MCA distribution. Multiple regression analysis showed this index to be positively correlated with the value of oxygen extraction fraction, with the presence of silent subcortical infarcts, and with the presence of ischemic heart disease, whereas it was negatively correlated with the treatment of hypertension with ARBs. In asymptomatic atherosclerotic ICA or MCA disease, hemodynamic compromise is associated with selective neuronal damage manifested as decreases in cortical BZRs in the noninfarcted cerebral cortex, whereas ARBs are associated with preservation of cortical BZRs.
収録刊行物
-
- Journal of cerebral blood flow and metabolism
-
Journal of cerebral blood flow and metabolism 31 (3), 953-961, 2011-03
Nature Publishing Group
- Tweet
キーワード
- asymptomatic
- benzodiazepine receptor
- carotid artery disease
- middle cerebral artery disease
- positron emission tomography
- Aged
- Angiotensin Receptor Antagonists/therapeutic use
- Atherosclerosis/diagnosis
- Atherosclerosis/drug therapy
- Atherosclerosis/metabolism
- Carotid Artery, Internal
- Cerebral Arterial Diseases/diagnosis
- Cerebral Arterial Diseases/drug therapy
- Cerebral Arterial Diseases/metabolism
- Cerebral Cortex/metabolism
- Cerebral Cortex/pathology
- Cerebral Cortex/radionuclide imaging
- Female
- Flumazenil/diagnostic use
- Humans
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Middle Cerebral Artery
- Neurons/metabolism
- Neurons/pathology
- Positron-Emission Tomography
- Receptors, GABA-A/drug effects
- Receptors, GABA-A/metabolism
- Regression Analysis
詳細情報 詳細情報について
-
- CRID
- 1050845760664666880
-
- NII論文ID
- 120004185035
-
- NII書誌ID
- AA12510484
-
- ISSN
- 15597016
- 0271678X
- https://id.crossref.org/issn/0271678X
-
- HANDLE
- 2433/156405
-
- PubMed
- 20877388
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- IRDB
- Crossref
- CiNii Articles
- KAKEN
- OpenAIRE
